| | | | | | | | |
(InΒ thousands) | Β Β Β Β | β | 2023 | β | Β Β Β Β | β | 2022 | β |
CASH FLOWS FROM OPERATING ACTIVITIES: | β | β | β | β | β | β | β | β |
Net earnings | β | $ | 410,549 | β | β | $ | 573,085 | β |
Adjustments to reconcile net earnings to net cash used in operating activities: | β | β | β | β | β | β | β | β |
β | β | β | β | β | β | β | β | β |
Depreciation | β | β | 80,432 | β | β | β | 68,881 | β |
Amortization of intangibles | β | β | 15,325 | β | β | β | 13,448 | β |
Expense associated with share-based and grant compensation arrangements | β | β | 26,068 | β | β | β | 19,979 | β |
Deferred income taxes (credit) | β | β | 113 | β | β | β | (269) | β |
Unrealized loss on investment and other | β | β | 362 | β | β | β | 8,453 | β |
Equity in loss of investee | β | β | 1,013 | β | β | β | 2,740 | β |
Net (gain) loss on sale and disposition of assets | β | β | (465) | β | β | β | 352 | β |
Changes in: | β | β | β | β | β | β | β | β |
Accounts receivable | β | β | (82,883) | β | β | β | (137,607) | β |
Inventories | β | β | 230,559 | β | β | β | (36,259) | β |
Accounts payable and cash overdraft | β | β | 49,093 | β | β | β | (11,247) | β |
Accrued liabilities and other | β | β | (18,363) | β | β | β | 31,490 | β |
NET CASH FROM OPERATING ACTIVITIES | β | β | 711,803 | β | β | β | 533,046 | β |
β | β | β | β | β | β | β | β | β |
CASH FLOWS USED IN INVESTING ACTIVITIES: | β | β | β | β | β | β | β | β |
Purchases of property, plant, and equipment | β | β | (130,947) | β | β | β | (113,725) | β |
Proceeds from sale of property, plant and equipment | β | β | 2,211 | β | β | β | 2,303 | β |
Acquisitions, net of cash received and purchase of equity method investment | β | β | (52,383) | β | β | β | (105,212) | β |
Purchases of investments | β | β | (26,333) | β | β | β | (16,925) | β |
Proceeds from sale of investments | β | β | 22,101 | β | β | β | 10,036 | β |
Other | β | β | (2,092) | β | β | β | 911 | β |
NET CASH USED IN INVESTING ACTIVITIES | β | β | (187,443) | β | β | β | (222,612) | β |
β | β | β | β | β | β | β | β | β |
CASH FLOWS USED IN FINANCING ACTIVITIES: | β | β | β | β | β | β | β | β |
Borrowings under revolving credit facilities | β | β | 18,915 | β | β | β | 570,700 | β |
Repayments under revolving credit facilities | β | β | (21,929) | β | β | β | (571,075) | β |
Repayments of debt | β | β | (29) | β | β | β | (1,957) | β |
Contingent consideration payments and other | β | β | (6,179) | β | β | β | (2,564) | β |
Proceeds from issuance of common stock | β | β | 2,087 | β | β | β | 2,110 | β |
Dividends paid to shareholders | β | β | (49,723) | β | β | β | (43,420) | β |
Distributions to noncontrolling interest | β | β | (7,355) | β | β | β | (12,023) | β |
Repurchase of common stock | β | β | (62,076) | β | β | β | (93,215) | β |
Other | β | β | 65 | β | β | β | (210) | β |
NET CASH USED IN FINANCING ACTIVITIES | β | β | (126,224) | β | β | β | (151,654) | β |
β | β | β | β | β | β | β | β | β |
Effect of exchange rate changes on cash | β | β | 3,199 | β | β | β | (139) | β |
NET CHANGE IN CASH AND CASH EQUIVALENTS | β | β | 401,335 | β | β | β | 158,641 | β |
β | β | β | β | β | β | β | β | β |
ALL CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD | β | β | 559,623 | β | β | β | 291,223 | β |
β | β | β | β | β | β | β | β | β |
ALL CASH AND CASH EQUIVALENTS, END OF PERIOD | β | $ | 960,958 | β | β | $ | 449,864 | β |
β | β | β | β | β | β | β | β | β |
Reconciliation of cash and cash equivalents and restricted cash: | β | β | β | β | β | β | β | β |
Cash and cash equivalents, beginning of period | β | $ | 559,397 | β | β | $ | 286,662 | β |
Restricted cash, beginning of period | β | β | 226 | β | β | β | 4,561 | β |
All cash and cash equivalents, beginning of period | β | $ | 559,623 | β | β | $ | 291,223 | β |
β | β | β | β | β | β | β | β | β |
Cash and cash equivalents, end of period | β | $ | 957,197 | β | β | $ | 449,135 | β |
Restricted cash, end of period | β | β | 3,761 | β | β | β | 729 | β |
All cash and cash equivalents, end of period | β | $ | 960,958 | β | β | $ | 449,864 | β |
β | β | β | β | β | β | β | β | β |